TAMPA, Fla., Oct. 10, 2016 -- The Eye Doctors, a full service eye care center in Tampa and New Port Richey, has announced that they are now providing an innovative new treatment for patients who suffer from dry eye caused by Meibomian Gland Dysfunction (MGD). MGD, a progressive disease that affects some 300 million people worldwide, stems from blockages in the oil-producing meibomian glands located in the eyelids. LipiFlow® unblocks the glands, allowing the glands to resume the secretion of oily lipids needed for a healthy tear film.
Developed as a result of 30 years of scientific research, LipiFlow® is an in-office procedure that uses directed heat and gentle pressure to liquefy and express the contents of meibomian glands. This cutting-edge treatment is FDA-cleared and scientifically proven. In a clinical study, 90 percent of patients achieved improvements in gland secretions after a single LipiFlow® treatment.
MGD can negatively impact long term vision and ocular health. If left untreated, MGD will worsen over time, leading to eye redness, dryness, irritation, burning, and eye fatigue. These symptoms can hinder daily activities such as reading, using the computer, wearing contact lenses, and being outdoors on windy days.
Patients who suffer from these symptoms should be screened for MGD as part of their routine comprehensive eye examination. Early identification of MGD can yield the best results for long term ocular health. LipiFlow® is an FDA-cleared treatment which safely and effectively treats the root cause of disease.
“Dry eye disease is one of the chief complaints that I hear from patients,” said Dr. Samuel Teske, optometrist at The Eye Doctors. “We are pleased to introduce LipiFlow® for our patients who are negatively impacted by MGD. Conventional therapies, such as warm compresses, over-the-counter wetting drops, ointments, and prescription drugs have failed to provide the relief that LipiFlow® offers. LipiFlow® is safe and the most effective treatment for MGD available today. Our patients have reported great improvement with their dry eye over the course of their treatment.”
About The Eye Doctors
The Eye Doctors provides an array of eye care services including comprehensive eye exams for all ages, dry eye treatment, eye disease management, and vision corrective services such as Ortho-K and CRT. Their team of eye care professionals have outstanding credentials to deliver the best care and outcomes for patients. The Eye Doctors utilizes the most advanced technology to deliver the best solutions safely and reliably to their patients.
Residents of the Tampa and New Port Richey communities who would like to schedule an appointment or who have questions regarding LipiFlow® treatments are invited to call The Eye Doctors at (813) 632-2020. For more information on the services and hours at this optometry clinic, visit their website at http://theeyedocs.com/.
The Eye Doctors, (813) 632-2020


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Apple Turns 50: From Garage Startup to AI Crossroads
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
First Western Ship Transits Strait of Hormuz Since Iran War Began
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 



